Inherited Cancer Panel

Comprehensive risk screening for 32 inherited cancers

Through NGS based genetic testing, iGenetic can provide a risk assessment for several hereditary cancers so that the clinician and patient can determine the appropriate intervention.

Uniqueness of iGenetic

Using a customized panel of 86 genes, iGenetic can leverage its NGS technology to assess the risk of 32 inherited cancers. This is valuable information for patients who have a history of hereditary cancers in the family as it can help the clinician and patient determine appropriate intervention.


Inherited Cancer Screening on NGS Platform

Method TAT Sample required
Next Generation Sequencing 4-6 weeks EDTA Blood
Method Next Generation Sequencing
TAT 4-6 weeks
Sample required EDTA Blood
How to Order:
Prior information needed to order this test.

Please contact us by phone or email to schedule a test.